Population diversity of cardiovascular outcome trials and real-world patients with diabetes in a Chinese tertiary hospital-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Population diversity of cardiovascular outcome trials and real-world patients with diabetes in a Chinese tertiary hospital

Published:2021-03-11 Issue:11 Volume:134 Page:1317-1323
ISSN:0366-6999
Container-title:Chinese Medical Journal
language:en
Short-container-title:

Author:

Zhou Yi-Ling,Zhang Yong-Gang,Zhang Rui,Zhou You-Lian,Li Nan,Wang Mi-Ye,Tian Hao-Ming,Li She-Yu

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,General Medicine

Reference38 articles.

1. Real-world evidence—What is it and what can it tell us?;Sherman;N Engl J Med,2016

2. Nonrandomized real-world evidence to support regulatory decision making: process for a randomized trial replication project;Franklin;Clin Pharmacol Ther,2020

3. Use of real-world evidence for healthcare decision-making in the Middle East: practical considerations and future directions;Akhras;Expert Rev Pharmacoecon Outcomes Res,2019

4. The role for pragmatic randomized controlled trials (pRCTs) in comparative effectiveness research;Chalkidou;Clin Trials,2012

5. Good clinical practice guidance and pragmatic clinical trials: Balancing the best of both worlds;Mentz;Circulation,2016

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Professional medical education approaches: mobilizing evidence for clinicians;Frontiers in Medicine;2023-07-28

2. Risk of diabetic ketoacidosis of SGLT2 inhibitors in patients with type 2 diabetes: a systematic review and network meta-analysis of randomized controlled trials;Frontiers in Pharmacology;2023-06-13

3. Benefits and harms of fibrate therapy in patients with type 2 diabetes: a systematic review and meta-analysis;Endocrine;2023-05-29

4. Impact of the COVID‐19 pandemic on cancer healthcare utilization in southwestern China to March 2021;Cancer Medicine;2023-05-11

5. Four-Year Increase in Step Cadence Is Associated with Improved Cardiometabolic Health in People with a History of Prediabetes;Medicine & Science in Sports & Exercise;2023-03-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3